Literature DB >> 9262075

Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. K.U. Leuven Coronary Surgery Program.

P Sergeant1, E Blackstone, B Meyns.   

Abstract

OBJECTIVE: First to identify the patient-, procedural- and surgical experience variables influencing the early and late survival after CABG. Second to identify patients likely to benefit, and those unlikely to benefit, from technical details aimed at improving the results of coronary artery bypass grafting (CABG).
METHODS: A consecutive series of 9600 patients who underwent CABG using a variety of revascularization methods between 1971 and 1992 were followed with 99.9% success. A multivariable time-related analysis was performed. Patient-specific predictions and nomograms were constructed from it to explore and validate the influences and interdependences of patient-variables with variations in details of the procedure.
RESULTS: The 1-, 10- and 20-year risk-unadjusted survival was 97, 81 and 50% respectively. Patient-variables influencing early survival included severity of symptoms, patient presentation and extent of coronary disease, while late survival was influenced importantly by left ventricular function and cardiac and non-cardiac comorbidity. Technical details of the operation influencing early survival included use of endarterectomy, while details such as use of arterial grafting, extensiveness of sequential grafting, completeness of revascularization and extent of grafting to small coronaries influenced late survival to a highly variable degree.
CONCLUSION: The early survival is neither improved nor worsened by single, multiple, sequential or complete arterial coronary reconstruction. The late survival is modestly improved with the use of an arterial graft to a major vessel, preferably but not exclusively to the anterior descendens, except for patients with limited life-expectancy. Differences in time-related survival with and without an arterial graft are nearly the same across all levels of ejection fraction. No late beneficial or detrimental effect was identified with more extensive use of arterial reconstructive surgery in multisystem disease.

Entities:  

Mesh:

Year:  1997        PMID: 9262075     DOI: 10.1016/s1010-7940(97)00134-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  16 in total

1.  The legacy of Bristol: public disclosure of individual surgeons' results.

Authors:  Bruce Keogh; David Spiegelhalter; Alan Bailey; James Roxburgh; Patrick Magee; Colin Hilton
Journal:  BMJ       Date:  2004-08-21

Review 2.  Atrial fibrillation in patients with coronary disease.

Authors:  Patrick M McCarthy; Jane Kruse
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

3.  Changing profile of elderly patients undergoing coronary bypass surgery.

Authors:  E C W Cloin; L Noyez
Journal:  Neth Heart J       Date:  2005-04       Impact factor: 2.380

4.  Mortality and recurrent cardiac events after coronary artery bypass graft: long term outcomes in a population study.

Authors:  P J Bradshaw; K Jamrozik; M Le; I Gilfillan; P L Thompson
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

5.  Impact of double internal thoracic artery grafts on long-term outcomes in coronary artery bypass grafting.

Authors:  D Danzer; J T Christenson; A Kalangos; G Khatchatourian; M Bednarkiewicz; B Faidutti
Journal:  Tex Heart Inst J       Date:  2001

6.  [Should we avoid cardiopulmonary bypass with diabetic patients?].

Authors:  A Albert; J Ennker; P Sergeant
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

7.  Surgical management of diffusely diseased coronary arteries.

Authors:  Gutti Ramasubrahmanyam; Karthik Panchanatheeswaran; Tej Kumar Varma Kalangi; Goli Nagasaina Rao
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-07

8.  Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success.

Authors:  Simon Schopka; Christof Schmid; Andreas Keyser; Ariane Kortner; Julia Tafelmeier; Claudius Diez; Leopold Rupprecht; Michael Hilker
Journal:  J Cardiothorac Surg       Date:  2010-05-05       Impact factor: 1.637

9.  Total arterial revascularisation as a primary strategy for coronary artery bypass grafting.

Authors:  M J Naik; Y Abu-Omar; A Alvi; N Wright; A Henderson; K Channon; J C Forfar; D P Taggart
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

10.  Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].

Authors:  David P Taggart; Belinda Lees; Alastair Gray; Douglas G Altman; Marcus Flather; Keith Channon
Journal:  Trials       Date:  2006-03-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.